Covidien launched the new HALO60 Ablation Catheter for endoscopic treatment of Barrett’s esophagus.
The device, which is now available in U.S., Canada, Australia and some European countries, was made for easy maneuverability and patient comfort. Additionally, it may prove to be an effective tool for cauterization when dealing with chronic bleeding conditions like gastric antral vascular ectasia and radiation proctitis.
The HALO60 Ablation Catheter is designed to be used independently or in conjunction with the commercially available HALO90 Ablation Catheter, a larger focal device, and HALO360+ Ablation Catheter, a balloon-based endoscopic ablation system for treating larger, circumferential areas of Barrett’s esophagus. All HALO products are based on patented technology that carefully controls the amount of energy delivered to the tissue to safely and effectively remove the diseased tissue and facilitate the re-growth of new, healthy tissue. Together, the products offer physicians a safe and convenient solution for the removal of Barrett’s esophagus.
A majority of patients with Barrett’s esophagus have short segments of diseased tissue where the esophagus meets the stomach. Featuring a small electrode mounted on the end of an endoscope, the HALO60 – so named because it has approximately 60% of the surface area of the larger HALO90 focal device – has a smaller footprint to help the physician move the device easily and efficiently. It can ease intubation and extubation in difficult anatomy and also may help the physician maneuver around the gastroesophageal junction.